It Is Not You Who Chooses Your Partner… But Your HLA Genes!

24/10/2018

Written by Nina Lauterbach, PhD (Field Application Scientist, Omixon) Animals, and us humans, are daily under attack by viruses and other pathogens. Fortunately, we are equipped with the Major Histocompatibility Complex (MHC) as an efficient and adaptable fighting mechanism to deal with these threatening events. This complex is encoded...

Automated NGS-based HLA Typing and Epitope Matching at the 44th ASHI Annual Meeting 2018

27/09/2018

Omixon announce today that Holotype HLA and other Omixon products will be featured among nine posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium on Thursday 10/4 will focus on the importance...

SFHI, October 4-5, 2018

25/09/2018

Join Omixon and our French distributor, Wiratech for SFHI 2018 in Amiens, France! Meet our team at our shared table. Read more about the conference here…

Omixon & PIRCHE® collaborate on Epitope Determination with NGS

17/09/2018

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...

Omixon at BSHI 2018 – Cardiff, Wales, September 5-6

31/08/2018

Join our small team, Afshan Ali (Sales Manager, EMEA) and Dr. Libor Kolesár (Field Application Scientist) for our Lunchtme Workshop on Friday, September 6 from 12:40 and learn more about the big question: whether laboratories should be pooling resources and scaling up in regional testing centres to achieve economies...